| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 88,689 | 98,252 | 97,561 | 123,058 | | Cost of Revenue | 50,826 | 54,427 | 56,003 | 75,356 | | | Gross Profit | 37,863 | 43,825 | 41,558 | 47,702 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,287 | 35,513 | 37,151 | 48,525 | | Non Recurring |
-
|
-
|
-
| 71,407 | | Others | 3,885 | 3,980 | 3,797 | 4,681 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,309) | 4,332 | 610 | (76,911) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 94 | 93 | 93 | 136 | | Earnings Before Interest And Taxes | (1,215) | 4,425 | 703 | (76,775) | | Interest Expense | 256 | 295 | 330 | 609 | | Income Before Tax | (1,471) | 4,130 | 373 | (77,384) | | Income Tax Expense | (61) | 504 | 37 | 29,759 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,410) | 3,626 | 336 | (107,143) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (895) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,410) | 3,626 | 336 | (108,038) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,410) | $3,626 | $336 | ($108,038) |
|
0.51% Nasdaq 
0.11 (4.20%) 
Income Statement
